Gepirone

(Exxua)

Gepirone

Drug updated on 11/17/2023

Dosage FormTablet (oral; 18.2 mg, 36.3 mg, 54.5 mg, and 72.6 mg)
Drug ClassSelective partial agonist of the 5-HT1A receptor
Ongoing and Completed StudiesClinicalTrials.gov

Indication

  • For the treatment of major depressive disorder (MDD) in adults.

Product Monograph / Prescribing Information

Document TitleYearSource
Exxua (gepirone) Prescribing Information.2023Fabre-Kramer Pharmaceuticals Inc., Houston, TX

Systematic Reviews / Meta-Analyses